These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4596069)

  • 41. [Betamethasone dipropionate. A dermocorticoid].
    Durepaire R; Bourgeois-Spinasse J; Cardinne A; Edelson Y; Benazéraf C; Futchbaum G; Girard J; Rousselet G; Grupper C
    Nouv Presse Med; 1975 Apr; 4(17):1285-6. PubMed ID: 1153285
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical evaluation on the long-term use of halometasone ointment in chronic eczema and psoriasis.
    Weitgasser H; Yawalkar SJ
    J Int Med Res; 1983; 11 Suppl 1():34-7. PubMed ID: 6339291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The clinical assessment of topical corticosteroid activity.
    Wilson L
    Br J Dermatol; 1976 Mar; 94 suppl 12():33-42. PubMed ID: 773412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Halogenation and topical corticosteroids: a comparison between the 17-butyrate esters of hydrocortisone and clobetasone in ointment bases.
    Allenby CF; Sparkes CG
    Br J Dermatol; 1981 Feb; 104(2):179-83. PubMed ID: 7011356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind controlled trial of betamethasone dipropionate 0.05% (Diproderm) in comparison with fluocinolone acetonide 0.025% (Synalar) in psoriasis and other steroid-responsive dermatoses.
    Afzelius HW; Jacobsen KU
    J Int Med Res; 1979; 7(5):411-4. PubMed ID: 387495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Studies on the systemic effect of extensively applied topical steroids].
    Holzmann H; Morsches B; Gebhardt R
    Arztl Forsch; 1972 May; 26(5):171-7. PubMed ID: 5068154
    [No Abstract]   [Full Text] [Related]  

  • 47. A double-blind controlled evaluation of Diproderm cream 0.05%, twice a day treatment in comparison with once a day treatment in eczema.
    Gärtner L; Tarras-Wahlberg C
    J Int Med Res; 1984; 12(1):59-61. PubMed ID: 6363158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
    Clark RF; Clement ER
    Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug trial: a comparison between the topical efficacy of 1 percent hydrocortisone and 0.2 percent fluocortolone.
    Portnoy B
    Australas J Dermatol; 1969 Dec; 10(3):183-4. PubMed ID: 4907403
    [No Abstract]   [Full Text] [Related]  

  • 50. Topical Corticosteroids International Symposium, Venice, May 1972. Introductory remarks.
    Craps L
    Acta Derm Venereol Suppl (Stockh); 1973; 53():9-11. PubMed ID: 4585162
    [No Abstract]   [Full Text] [Related]  

  • 51. Pituitary-adrenal function after prolonged use of topical corticosteroids.
    Munro DD; Clift DC
    Br J Dermatol; 1973 Apr; 88(4):381-5. PubMed ID: 4712220
    [No Abstract]   [Full Text] [Related]  

  • 52. A double-blind comparison of fluocinonide and betamethasone valerate ointments.
    McCuistion CH; Schoch EP; Warthan TL
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):44-7. PubMed ID: 4632505
    [No Abstract]   [Full Text] [Related]  

  • 53. Controlled trial of the treatment of atopic eczema with a urea-hydrocortisone preparation versus betamethasone 17-valerat.
    Almeyda J; Fry L
    Br J Dermatol; 1973 May; 88(5):493-5. PubMed ID: 4715126
    [No Abstract]   [Full Text] [Related]  

  • 54. [Our experience with Acépreval a new topical non-fluorinated cortisone in dermatological therapy].
    Dumitriu R; Bruni G
    Schweiz Rundsch Med Prax; 1973 Jul; 62(31):970-2. PubMed ID: 4270141
    [No Abstract]   [Full Text] [Related]  

  • 55. Letter: Double-blind studies in dermatology.
    JAMA; 1973 Dec; 226(10):1229-30. PubMed ID: 4584418
    [No Abstract]   [Full Text] [Related]  

  • 56. Fluocinonide compared with betamethasone in the treatment of eczema and psoriasis.
    Ronn HH
    Practitioner; 1976 Jun; 216(1296):704-6. PubMed ID: 781661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream.
    van Dijk E; Bakkers EJ; Go MJ; Montnor LP; Roessel FE; van der Wateren AR; Wuite J
    Cutis; 1983 Sep; 32(3):284-5, 287. PubMed ID: 6354613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Control of the bioavailability of a topical steroid; comparison of desonide creams 0.05% and 0.1% by vasoconstrictor studies and clinical trials.
    Barry BW; Fyrand O; Woodford R; Ulshagen K; Hogstad G
    Clin Exp Dermatol; 1987 Nov; 12(6):406-9. PubMed ID: 3333023
    [No Abstract]   [Full Text] [Related]  

  • 59. A comparison of the effect of various topically active steroids on the clinical and histological features of psoriasis.
    Goodwin PG; Hamilton S; Fry L
    Br J Dermatol; 1973 Jul; 89(1):61-6. PubMed ID: 4596154
    [No Abstract]   [Full Text] [Related]  

  • 60. [Means of increasing the therapeutic efficacy of corticosteroid ointments].
    Shekrota GS
    Vestn Dermatol Venerol; 1968 Mar; 42(3):65-6. PubMed ID: 5741249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.